Cell-penetrating peptides in protein mimicry and cancer therapeutics

Area of Science:

• Oncology
• Drug Delivery
• Molecular Biology

Background:

• Anticancer drug development requires targeted delivery to cancer cells, minimizing damage to healthy tissues.
• Cell-penetrating peptides (CPPs) are established facilitators of intracellular delivery and are advancing towards targeted anticancer applications.
• While not yet clinically approved, CPP technology has progressed to clinical trials for cancer treatment.

Purpose of the Study:

• To review cell-penetrating peptides (CPPs) for targeted anticancer drug delivery.
• To discuss CPP classification, cargo internalization mechanisms, and conjugation strategies.
• To highlight tumor-targeting strategies using CPPs and their potential in cancer therapy and diagnostics.

Main Methods:

• Review of existing literature on cell-penetrating peptides (CPPs) in cancer research.
• Analysis of strategies for enhancing CPP specificity, including tumor microenvironment exploitation and tumor homing peptides.
• Examination of CPP conjugation to anticancer moieties, therapeutic proteins, and antibody/antigen conjugates.

Main Results:

• CPPs demonstrate significant potential for targeted delivery of anticancer agents, including cytostatic drugs.
• Strategies for building tumor specificity into CPP constructs are being developed and refined.
• CPP conjugates show promise for targeting protein-protein interactions crucial for tumor survival and progression.

Conclusions:

• Cell-penetrating peptides (CPPs) are a promising platform for developing targeted cancer therapies and diagnostics.
• Exploiting the tumor microenvironment and incorporating tumor homing peptides enhance CPP selectivity.
• Further research and clinical trials are essential to realize the full potential of CPP-aided drug delivery in oncology.